LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
<!--StartFragment--> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Background: Imatinib has become first line therapy in c...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/8428 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850088433205116928 |
|---|---|
| author | Michelina Santopietro Giuseppina Loglisci Roberto Latagliata Corrado Girmenia Massimo Breccia Vincenzo Federico Luigi Petrucci Alessandra Serrao Adriano Salaroli Giuliana Alimena |
| author_facet | Michelina Santopietro Giuseppina Loglisci Roberto Latagliata Corrado Girmenia Massimo Breccia Vincenzo Federico Luigi Petrucci Alessandra Serrao Adriano Salaroli Giuliana Alimena |
| author_sort | Michelina Santopietro |
| collection | DOAJ |
| description | <!--StartFragment--> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Background: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective consequences during the treatment with this drug in large series of chronic phase patients. </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Material and methods: From January 2001 to September 2006 we treated with imatinib 250 patients in first line (early CP) or after interferon failure (late CP), out of clinical trials and recorded all the bacterial and viral infections occurred.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Results: We recorded a similar incidence of bacterial and viral infections both in first line and late CP patients (respectively, 16% and 13%) during 3.5 years of follow-up. Analysis of presenting features predisposing to infections revealed differences only in late CP patients, with elevated percentage of high Sokal risk patients and a more longer median time from diagnosis to start of imatinib.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Conclusions: Opportunistic infections and reactivation of Herpes Zoster are observed during imatinib therapy at very low incidence.</span></p> <!--EndFragment--> |
| format | Article |
| id | doaj-art-9a90d56bf7c5498a9db1d9f61dc2fc14 |
| institution | DOAJ |
| issn | 2035-3006 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-9a90d56bf7c5498a9db1d9f61dc2fc142025-08-20T02:43:00ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062011-01-0131e2011021e2011021LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASEMichelina SantopietroGiuseppina LoglisciRoberto LatagliataCorrado GirmeniaMassimo BrecciaVincenzo FedericoLuigi PetrucciAlessandra SerraoAdriano SalaroliGiuliana Alimena<!--StartFragment--> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Background: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective consequences during the treatment with this drug in large series of chronic phase patients. </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Material and methods: From January 2001 to September 2006 we treated with imatinib 250 patients in first line (early CP) or after interferon failure (late CP), out of clinical trials and recorded all the bacterial and viral infections occurred.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Results: We recorded a similar incidence of bacterial and viral infections both in first line and late CP patients (respectively, 16% and 13%) during 3.5 years of follow-up. Analysis of presenting features predisposing to infections revealed differences only in late CP patients, with elevated percentage of high Sokal risk patients and a more longer median time from diagnosis to start of imatinib.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: Arial; mso-ansi-language: EN-GB;" lang="EN-GB">Conclusions: Opportunistic infections and reactivation of Herpes Zoster are observed during imatinib therapy at very low incidence.</span></p> <!--EndFragment-->http://www.mjhid.org/article/view/8428chronic myeloid leukemia, imatinib, infections, bacterial, herpes Zoster |
| spellingShingle | Michelina Santopietro Giuseppina Loglisci Roberto Latagliata Corrado Girmenia Massimo Breccia Vincenzo Federico Luigi Petrucci Alessandra Serrao Adriano Salaroli Giuliana Alimena LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE Mediterranean Journal of Hematology and Infectious Diseases chronic myeloid leukemia, imatinib, infections, bacterial, herpes Zoster |
| title | LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE |
| title_full | LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE |
| title_fullStr | LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE |
| title_full_unstemmed | LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE |
| title_short | LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE |
| title_sort | low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase |
| topic | chronic myeloid leukemia, imatinib, infections, bacterial, herpes Zoster |
| url | http://www.mjhid.org/article/view/8428 |
| work_keys_str_mv | AT michelinasantopietro lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT giuseppinaloglisci lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT robertolatagliata lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT corradogirmenia lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT massimobreccia lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT vincenzofederico lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT luigipetrucci lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT alessandraserrao lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT adrianosalaroli lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase AT giulianaalimena lowincidencerateofopportunisticandviralinfectionsduringimatinibtreatmentinchronicmyeloidleukemiapatientsinearlyandlatechronicphase |